Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jacobs

Showing results (731-740 of 791) with videos related to

Pageof 80
Sort By:
Rheumatology (Oxford, England)|February 9, 2021
Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping studyNadia M T Roodenrijs, Marlies C van der Goes, Paco M J Welsing, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Metabolic Models, in Silico Trials, and AlgorithmsAli Cinar, Ananda Basu, B Wayne Bequette, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2023
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a ChangeTom G Jacobs, Vivian Mumbiro, Moses Chitsamatanga, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoidsJ N Hoes, M C van der Goes, D H van Raalte, et al.
Diabetologia|March 19, 2024
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohortLauren V Turner, Martin Chase Marak, Robin L Gal, et al.
Trials|April 20, 2019
Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritisN J Besselink, A A A Westgeest, R Klaasen, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Metabolic Models, in Silico Trials, and AlgorithmsAli Cinar, Ananda Basu, B Wayne Bequette, et al.
Annals of the Rheumatic Diseases|May 16, 2018
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictorsXavier M Teitsma, Johannes W G Jacobs, Paco M J Welsing, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Plasma proteomics link menopause timing to brain aging and dementia riskMadeline Wood Alexander, Brendan Wood, Hamilton See-Hwee Oh, et al.
Pageof 80

Showing results (731-740 of 791) with videos related to

Sort By:
Pageof 80
Rheumatology (Oxford, England)|February 9, 2021
Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping studyNadia M T Roodenrijs, Marlies C van der Goes, Paco M J Welsing, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Metabolic Models, in Silico Trials, and AlgorithmsAli Cinar, Ananda Basu, B Wayne Bequette, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2023
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a ChangeTom G Jacobs, Vivian Mumbiro, Moses Chitsamatanga, et al.
Annals of the Rheumatic Diseases|July 23, 2013
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseasesN Duru, M C van der Goes, J W G Jacobs, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoidsJ N Hoes, M C van der Goes, D H van Raalte, et al.
Diabetologia|March 19, 2024
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohortLauren V Turner, Martin Chase Marak, Robin L Gal, et al.
Trials|April 20, 2019
Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritisN J Besselink, A A A Westgeest, R Klaasen, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Metabolic Models, in Silico Trials, and AlgorithmsAli Cinar, Ananda Basu, B Wayne Bequette, et al.
Annals of the Rheumatic Diseases|May 16, 2018
Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictorsXavier M Teitsma, Johannes W G Jacobs, Paco M J Welsing, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Plasma proteomics link menopause timing to brain aging and dementia riskMadeline Wood Alexander, Brendan Wood, Hamilton See-Hwee Oh, et al.
Pageof 80